Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Dean Website

Michael Dean, Ph.D.

Selected Publications

1)  Guo G, Sun X, Chen C, Wu S, Huang P, Li Z, Dean M, Huang Y, Jia W, Zhou Q, Tang A, Yang Z, Li X, Song P, Zhao X, Ye R, Zhang S, Lin Z, Qi M, Wan S, Xie L, Fan F, Nickerson ML, Zou X, Hu X, Xing L, Lv Z, Mei H, Gao S, Liang C, Gao Z, Lu J, Yu Y, Liu C, Li L, Fang X, Jiang Z, Yang J, Li C, Zhao X, Chen J, Zhang F, Lai Y, Lin Z, Zhou F, Chen H, Chan HC, Tsang S, Theodorescu D, Li Y, Zhang X, Wang J, Yang H, Gui Y, Wang J, Cai Z.
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.
Nat. Genet. 45: 1459-63, 2013.
2)  Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N.
Identification of the cystic fibrosis gene: chromosome walking and jumping.
Science. 245: 1059-65, 1989.
3)  Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah A, Rinaldo C, Detels R, O'Brien SJ.
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
Science. 273: 1856-62, 1996.
4)  Dean M, Fojo T, Bates S.
Tumour stem cells and drug resistance.
Nat. Rev. Cancer. 5: 275-84, 2005.
5)  Allikmets R, Schriml LM, Hutchinson A, Romano-Spica V, Dean M.
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.
Cancer Res. 58: 5337-9, 1998.
6)  Jiménez-Morales S, Jiménez-Ruíz JL, Del Río-Navarro BE, Navarro-Olivos E, Escamilla-Guerrero G, Savan R, Dean M, Orozco L.
CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients.
Mol. Biol. Rep. 41: 2109-17, 2014.
7)  Dean M, Bendfeldt G, Lou H, Giron V, Garrido C, Valverde P, Barnoya M, Castellanos M, Jiménez-Morales S, Luna-Fineman S.
Increased incidence and disparity of diagnosis of retinoblastoma patients in Guatemala.
Cancer Lett. [Epub ahead of print], 2014.
8)  Garrido C, Santizo VG, Müllers P, Soriano DR, Avila GB, Dean M, Jimenez-Morales S.
Frequency of thiopurine S-methyltransferase mutant alleles in indigenous and admixed Guatemalan patients with acute lymphoblastic leukemia.
Med. Oncol. 30: 474, 2013.
9)  Dean M, Lou H.
Genetics and genomics of prostate cancer.
Asian J. Androl. 15: 309-13, 2013.
10)  Perez-Andreu V, Roberts KG, Harvey RC, Yang W, Cheng C, Pei D, Xu H, Gastier-Foster J, E S, Lim JY, Chen I, Fan Y, Devidas M, Borowitz MJ, Smith C, Neale G, Burchard EG, Torgerson DG, Klussmann FA, Villagran CR, Winick NJ, Camitta BM, Raetz E, Wood B, Yue F, Carroll WL, Larsen E, Bowman WP, Loh ML, Dean M, Bhojwani D, Pui C, Evans WE, Relling MV, Hunger SP, Willman CL, Mullighan CG, Yang JJ.
Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.
Nat. Genet. 45: 1494-8, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 6/18/2014.